×

Anne Wojcicki

Anne Wojcicki CNBC Next 25
Benjamin Wachenje

Title: Co-founder and CEO, 23andMe

Born: July 28, 1973, San Mateo, California

Education: BS in biology, Yale University

Early Marker: Spent the last 10 years as a health-care investment analyst, focused mainly on biotech companies.

Big Idea: Named for the 23 pairs of chromosomes in a human cell, 23andMe sells personal genome-cell tests so individuals can explore their DNA. The FDA blocked the company's initial efforts to sell health-related reports that reveal a customer's health condition and genetic background, but the company recently gained approval to offer the service in Canada.

Wave of the Future: Genomics

Latest Special Reports

  • Take an in-depth look at the world of modern medicine - examining the treatments, companies and people making a difference in the way we treat illness and injuries today, and laying the foundation for the medical treatments of tomorrow.

  • A trader works on the floor of the New York Stock Exchange.

    Using ETFs investors can now span the globe in their portfolios. It’s now more important than ever to diversify assets.

  • Trading Nation

    Where headlines become opportunities.

CNBC25: Rebels, Icons and Leaders